Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review

• Published in: World journal of gastroenterology : WJG Vol. 21; no. 39; pp. 11185 - 11198
• Main Authors: de'Angelis, Nicola, Landi, Filippo, Carra, Maria Clotilde, Azoulay, Daniel
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 21.10.2015
• Subjects: Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - secondary; Carcinoma, Hepatocellular - surgery; carcinoma;Liver; hepatocellular; Humans; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Liver Neoplasms - surgery; Liver Transplantation - adverse effects; Liver Transplantation - mortality; Neoplasm Recurrence, Local - mortality; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - therapy; Niacinamide - adverse effects; Niacinamide - analogs & derivatives; Niacinamide - therapeutic use; Phenylurea Compounds - adverse effects; Phenylurea Compounds - therapeutic use; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - therapeutic use; Recurrent; Reoperation; Risk Factors; Survival Analysis; Systematic Reviews; Time Factors; transplan; Treatment Outcome; Trans-arterial chemoembolization; Tumor recurrence; Sorafenib; Recurrent hepatocellular carcinoma; Surgical resection; Systematic review; Liver transplantation

AIM: To investigate the efficacy(survival) and safety of treatments for recurrent hepatocellular carcinoma(HCC) in liver transplantation(LT) patients.METHODS: Literature search was performed on available online databases without a time limit until January 2015. Clinical studies describing survival a...